-       Report 
- October 2025
-  452 Pages 
- Global 
   From       €5206EUR$5,850USD£4,582GBP 
          -       Report 
- October 2025
-  250 Pages 
- Global 
   From       €3995EUR$4,490USD£3,517GBP 
          -       Report 
- September 2025
-  250 Pages 
- Global 
   From       €3995EUR$4,490USD£3,517GBP 
          -       Report 
- September 2025
-  250 Pages 
- Global 
   From       €3995EUR$4,490USD£3,517GBP 
          -       Report 
- April 2025
-  250 Pages 
- Global 
   From       €3995EUR$4,490USD£3,517GBP 
           -       Report 
- February 2025
-  200 Pages 
- Global 
   From       €3995EUR$4,490USD£3,517GBP 
          -       Report 
- February 2025
-  200 Pages 
- Global 
   From       €3995EUR$4,490USD£3,517GBP 
          -       Report 
- October 2025
-  193 Pages 
- Global 
   From       €5206EUR$5,850USD£4,582GBP 
          -       Report 
- September 2025
-  250 Pages 
- Global 
   From       €3995EUR$4,490USD£3,517GBP 
          -       Report 
- April 2025
-  200 Pages 
- Global 
   From       €3995EUR$4,490USD£3,517GBP 
          -       Report 
- July 2025
-  350 Pages 
- Global 
   From       €4404EUR$4,949USD£3,877GBP 
          -       Report 
- June 2025
-  400 Pages 
- Global 
   From       €4404EUR$4,949USD£3,877GBP 
          -       Report 
- June 2025
-  400 Pages 
- Global 
   From       €4404EUR$4,949USD£3,877GBP 
          -       Report 
- September 2025
-  150 Pages 
- Global 
   From       €3426EUR$3,850USD£3,016GBP 
          -       Report 
- February 2024
-  120 Pages 
- Global 
   From       €4227EUR$4,750USD£3,721GBP 
          -       Report 
- October 2023
-  145 Pages 
- Global 
   From       €2803EUR$3,150USD£2,467GBP 
          -       Report 
- April 2023
-  147 Pages 
- Global 
   From       €4404EUR$4,949USD£3,877GBP 
          -       Report 
- July 2024
-  200 Pages 
- Global 
   From       €4404EUR$4,949USD£3,877GBP 
          -       Report 
- March 2023
-  36 Pages 
- Global 
   From       €1735EUR$1,950USD£1,527GBP 
          -       Report 
- January 2024
-  175 Pages 
- United States 
        €3381EUR$3,800USD£2,977GBP 
       
      Psoriatic Arthritis is a type of inflammatory arthritis that affects individuals with psoriasis, a chronic skin condition. It is a form of spondyloarthropathy, a group of inflammatory joint diseases that affect the spine and other joints. Symptoms of Psoriatic Arthritis include joint pain, stiffness, swelling, and tenderness. It can also cause fatigue, eye inflammation, and nail changes. Treatment options include non-steroidal anti-inflammatory drugs, disease-modifying antirheumatic drugs, biologic    agents, and physical therapy.
The Psoriatic Arthritis market is a subset of the Allergy and Immunology market. It is a growing market, driven by the increasing prevalence of psoriasis and the need for effective treatments. The market is expected to benefit from the development of new treatments and the increasing awareness of the condition.
Companies in the Psoriatic Arthritis market include AbbVie, Amgen, Celgene, Eli Lilly, Janssen, Novartis, Pfizer, and UCB. Show Less   Read more